Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ID: DRG0YNODF)
ADC Name
KA-3123-LD38
Synonyms
KA-3123-LD38
   Click to Show/Hide
Organization
Kyinno Biotechnology Co., Ltd.; Shanghai Escugen Biotechnology Co., Ltd.
Drug Status
Investigative
Antibody Name
Undisclosed
Antigen Name
Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (HER3)
  Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed
Combination Type
LD38
2027 Update
ADC-specific functional property
Binding Affinity
Click To Hide/Show 2 ADC-specific functional property Data
Dissocation Constant (Kd) Binding Target Description Reference
<0.01 nM
B7H3
KA-3123-LD38 binds to B7H3 with high affinity, with a Kd of less than 0.01 nM, while its affinity for EGFR is weaker, with a Kd greater than 10 nM.
[1]
>10 nM
EGFR
KA-3123-LD38 binds to B7H3 with high affinity, with a Kd of less than 0.01 nM, while its affinity for EGFR is weaker, with a Kd greater than 10 nM.
[1]
References
Ref 1 KA-3123-LD38: a novel bispecific antibody-drug conjugate (ADC) targeting EGFR and B7H3 with a DNA topoisomerase I inhibitor payload